[ad_1] Imaging Contract Analysis Group (iCRO) from Bayer providing tailor-made companies that may span your complete imaging research cycle from idea to completionSupporting early analysis by means of Section IV trials and Software program as a Medical Gadget (SaMD) growth for pharmaceutical, biotech, medical gadget, and digital well being firms25+ years of experience because the Imaging Core Lab for Bayer, supporting greater than 200 medical trials globallyBayer can be showcasing Centafore, its companies and know-how at this yr’s Annual Assembly of the American Society of Scientific Oncology (ASCO) in Chicago from Might 30 until June 3 WHIPPANY, N.J.–(BUSINESS WIRE)–Bayer at this time introduced the launch of its Imaging Core Lab Companies beneath the model title Centafore. With over 25 years of expertise supporting greater than 200 medical trials at Bayer and its arm’s size firms globally, Centafore is now positioned as a definite Imaging answer supplier, providing tailor-made companies for exterior prospects to assist their medical trials and Software program as a Medical Gadget (SaMD) growth throughout numerous therapeutic areas and growth phases. Attendees of the 2025 Annual Assembly of the American Society of Scientific Oncology (ASCO) will get the possibility to be taught extra concerning the Centafore crew, know-how and its companies in Chicago from Might 30 until June 3 (Sales space #24152). Centafore gives know-how and companies for picture administration, processing, and interpretation, empowering research sponsors with skilled venture administration and facilitating superior analyses of imaging information. Its intensive community consists of skilled imaging professionals like board-certified radiologists, enabling prospects to successfully handle research throughout greater than 50 nations. “Centafore represents a major leap ahead in our dedication to enhancing the panorama of medical trial imaging and advancing the event of recent medicines and healthcare options,” mentioned Nelson Ambrogio, President of Radiology at Bayer. “By leveraging our intensive expertise and experience, we're devoted to offering our prospects with top quality imaging companies that meet their particular wants in medical analysis. By means of Centafore, we purpose to boost the reliability of trial outcomes and assist knowledgeable decision-making within the growth of investigational medicines, in the end benefiting sufferers and enhancing their high quality of care.” Centafore’s companies assist a variety of therapeutic areas, together with oncology, cardiovascular, CNS, dermatology, girls’s well being, pediatrics, and digital well being. It goals to assist pharmaceutical, biotech, medical gadget and digital well being firms with early analysis by means of Section IV trials and SaMD growth, and adherence to regulatory and information privateness compliance requirements. As a part of Bayer’s ongoing efforts to assist international healthcare startups, the Imaging Core Lab Companies of Bayer have been first introduced at ECR 2024. Centafore is already collaborating with organizations resembling OBIO® and Luxsonic Applied sciences to leverage medical imaging as a vital device for enhancing decision-making in medical trials and software program as a medical gadget (SaMD) growth. About Centafore Centafore is an Imaging Contract Analysis Group (iCRO) that helps early analysis by means of section IV trials and Software program as a Medical Gadget (SaMD) growth for pharma, biotech, medical gadget and digital well being firms. For over 25 years, it has been the first, trusted iCRO for Bayer, enjoying an important function in advancing the corporate’s drug pipeline – and now, prolonged its experience to exterior prospects beneath the model title Centafore, delivering high-quality assist for imaging research and analysis initiatives throughout the business. About Bayer in Radiology Constructing on a century of experience, Bayer is dedicated to revolutionary merchandise and high-quality companies in diagnostic imaging to boost affected person care. Its main radiology portfolio options distinction brokers and gadgets for exact administration throughout modalities together with computed tomography (CT), X-ray and magnetic resonance imaging (MRI), and positron emission tomography (PET). Bayer’s complete choices additionally embody informatics options, a curated market with digital and synthetic intelligence (AI) enabled functions. In 2024, Bayer’s radiology merchandise generated €2.1 billion in international gross sales. Dedicated to analysis and innovation, Bayer continues to advance medical imaging with the last word aim to enhance affected person outcomes. About Bayer Bayer is a world enterprise with core competencies within the life science fields of well being care and diet. According to its mission, “Well being for all, Starvation for none,” the corporate’s services are designed to assist folks and the planet thrive by supporting efforts to grasp the most important challenges introduced by a rising and growing older international inhabitants. Bayer is dedicated to driving sustainable growth and producing a optimistic affect with its companies. On the similar time, the Group goals to extend its incomes energy and create worth by means of innovation and progress. The Bayer model stands for belief, reliability and high quality all through the world. In fiscal 2024, the Group employed round 93,000 folks and had gross sales of 46.6 billion euros. R&D bills amounted to six.2 billion euros. For extra info, go to www.bayer.com. Discover extra info at https://pharma.bayer.com/Observe us on LinkedIn: Bayer | Prescription drugsObserve us on Twitter: @BayerPharma Ahead-Wanting Statements This launch could include forward-looking statements based mostly on present assumptions and forecasts made by Bayer administration. Numerous identified and unknown dangers, uncertainties and different elements may result in materials variations between the precise future outcomes, monetary scenario, growth or efficiency of the corporate and the estimates given right here. These elements embody these mentioned in Bayer’s public reviews which can be found on the Bayer web site at www.bayer.com. The corporate assumes no legal responsibility in any way to replace these forward-looking statements or to adapt them to future occasions or developments. Contacts International media contact:Simone Leyendecker, telephone +49 174 9508190E-mail: simone.leyendecker@bayer.com US media contact:Jennifer Might, telephoneE-mail: jennifer.could@bayer.com [ad_2]
